X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (98) 98
Patent (52) 52
Publication (14) 14
Newspaper Article (4) 4
Book Review (2) 2
Book Chapter (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (65) 65
chemistry (48) 48
metallurgy (48) 48
microbiology (44) 44
biochemistry (42) 42
humans (40) 40
beer (36) 36
compositions thereof (36) 36
culture media (36) 36
enzymology (36) 36
microorganisms or enzymes (36) 36
mutation or genetic engineering (36) 36
propagating, preserving or maintaining microorganisms (36) 36
spirits (36) 36
vinegar (36) 36
wine (36) 36
animals (28) 28
human necessities (27) 27
hygiene (27) 27
medical or veterinary science (27) 27
preparations for medical, dental, or toilet purposes (27) 27
organic chemistry (26) 26
chemistry, medicinal (16) 16
investigating or analysing materials by determining theirchemical or physical properties (16) 16
measuring (16) 16
mice (16) 16
physics (16) 16
testing (16) 16
compositions or test papers therefor (15) 15
condition-responsive control in microbiological orenzymological processes (15) 15
hiv (15) 15
measuring or testing processes involving enzymes, nucleicacids or microorganisms (15) 15
processes of preparing such compositions (15) 15
specific therapeutic activity of chemical compounds ormedicinal preparations (15) 15
alzheimers-disease (14) 14
proteins (14) 14
virology (14) 14
viruses (14) 14
peptides (13) 13
heterocyclic compounds (12) 12
immunology (12) 12
research (12) 12
structure-activity relationship (12) 12
general tagging of cross-sectional technologies spanning over several sections of the ipc (11) 11
general tagging of new technological developments (11) 11
health aspects (11) 11
infection (11) 11
infections (11) 11
protein (11) 11
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (11) 11
technologies for adaptation to climate change (11) 11
technologies or applications for mitigation or adaptation againstclimate change (11) 11
analysis (10) 10
cells (10) 10
female (10) 10
rna interference (10) 10
alzheimer's disease (9) 9
amyloid precursor protein secretases - antagonists & inhibitors (9) 9
cells, cultured (9) 9
chemistry, organic (9) 9
design (9) 9
genomics (9) 9
hela cells (9) 9
identification (9) 9
multidisciplinary sciences (9) 9
nucleic acids (9) 9
vaccines (9) 9
anti-hiv agents - pharmacology (8) 8
biochemistry & molecular biology (8) 8
cell line (8) 8
derivatives thereof (8) 8
genes (8) 8
genomes (8) 8
hiv-1 - drug effects (8) 8
hiv-1 - genetics (8) 8
human immunodeficiency virus (8) 8
neurosciences (8) 8
nucleosides (8) 8
nucleotides (8) 8
respiratory syncytial virus (8) 8
studies (8) 8
sugars (8) 8
antibodies (7) 7
aspartic acid endopeptidases - antagonists & inhibitors (7) 7
brain (7) 7
dna (7) 7
enzyme inhibitors - pharmacology (7) 7
enzymes (7) 7
expression (7) 7
gene expression (7) 7
genetic aspects (7) 7
in-vivo (7) 7
medicine (7) 7
rats (7) 7
research article (7) 7
amyloid precursor protein secretases - metabolism (6) 6
antibodies, viral - immunology (6) 6
cell biology (6) 6
cercopithecus aethiops (6) 6
crystallography, x-ray (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Proceedings of the National Academy of Sciences, ISSN 0027-8424, 12/2013, Volume 110, Issue 51, pp. E4997 - E5005
Human cytomegalovirus (HCMV) can cause serious morbidity/ mortality in transplant patients, and congenital HCMV infection can lead to birth defects. Developing... 
Antiviral antibody | Monoclonal antibody | NATURAL INFECTION | VIRUS-INFECTION | LINKED-IMMUNOSORBENT-ASSAY | MULTIDISCIPLINARY SCIENCES | PRIMARY INFECTION | SMOOTH-MUSCLE | ORGAN TRANSPLANT RECIPIENTS | CMV-HYPERIMMUNE GLOBULIN | antiviral antibody | EPITHELIAL-CELLS | ENDOTHELIAL-CELLS | monoclonal antibody | ANTIBODY-RESPONSE | Complementarity Determining Regions - genetics | Humans | Multiprotein Complexes - genetics | Cytomegalovirus Infections - immunology | Cytomegalovirus Infections - genetics | Immunoglobulin Light Chains - genetics | Antibodies, Neutralizing - immunology | Cytomegalovirus Infections - prevention & control | Female | Membrane Glycoproteins - immunology | Immunoglobulin Heavy Chains - immunology | Antibodies, Monoclonal - immunology | Cytomegalovirus Vaccines - genetics | Immunoglobulin Light Chains - immunology | Cytomegalovirus - genetics | Rabbits | Viral Envelope Proteins - genetics | Antibodies, Neutralizing - genetics | Membrane Glycoproteins - genetics | Antibodies, Monoclonal - genetics | Cytomegalovirus - immunology | Animals | Complementarity Determining Regions - immunology | Antibodies, Viral - immunology | Viral Envelope Proteins - immunology | Cytomegalovirus Vaccines - immunology | Antibodies, Viral - genetics | Immunoglobulin Heavy Chains - genetics | Multiprotein Complexes - immunology | Antigens | Immunology | Monoclonal antibodies | Viruses | Glycoproteins | Vaccines | Gene expression | Index Medicus | Biological Sciences | PNAS Plus
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2014, Volume 9, Issue 8, pp. e102684 - e102684
Selective histone deacetylase (HDAC) inhibitors have emerged as a potential anti-latency therapy for persistent human immunodeficiency virus type 1 (HIV-1)... 
RECRUITMENT | THERAPY | LONG TERMINAL REPEAT | MULTIDISCIPLINARY SCIENCES | IMMUNODEFICIENCY-VIRUS TYPE-1 | CD4(+) T-CELLS | HISTONE DEACETYLASE INHIBITORS | ESTABLISHMENT | IDENTIFICATION | NF-KAPPA-B | EXPRESSION | Anti-HIV Agents - pharmacology | RNA, Small Interfering - genetics | HIV-1 - pathogenicity | Virus Latency | Humans | HIV Infections - enzymology | CD4-Positive T-Lymphocytes - enzymology | HIV-1 - physiology | Gene Deletion | Histone Deacetylase 1 - antagonists & inhibitors | CD4-Positive T-Lymphocytes - virology | Histone Deacetylase 1 - genetics | Histone Deacetylase 2 - genetics | Promoter Regions, Genetic | Histone Deacetylases - genetics | Signal Transduction | HIV-1 - drug effects | Histone Deacetylase 2 - antagonists & inhibitors | HIV Infections - genetics | HIV Infections - virology | Gene Expression Regulation | Histone Deacetylases - deficiency | Host-Pathogen Interactions | Histone Deacetylase 2 - deficiency | Histone Deacetylase 1 - deficiency | HIV Infections - drug therapy | Histone Deacetylase Inhibitors - pharmacology | CD4-Positive T-Lymphocytes - drug effects | Cell Line, Transformed | RNA, Small Interfering - metabolism | RNA | T cells | HIV (Viruses) | Health aspects | HIV infection | Analysis | Histone deacetylase | Transcription factors | Transcription | Viruses | Infections | Lymphocytes T | Kinases | Gene expression | Ribonucleic acid--RNA | CD4 antigen | Latency | Virology | Immunology | Depletion | Inhibitors | Lymphocytes | Antiretroviral agents | Human immunodeficiency virus--HIV | Cell cycle | Inhibition | HDAC2 protein | Index Medicus | Ribonucleic acid | HIV | Human immunodeficiency virus
Journal Article
Vaccine, ISSN 0264-410X, 12/2018, Volume 36, Issue 52, pp. 8119 - 8130
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2016, Volume 11, Issue 10, pp. e0164789 - e0164789
Infection with Respiratory Syncytial Virus (RSV) causes both upper and lower respiratory tract disease in humans, leading to significant morbidity and... 
ANTIBODIES | RSV F | PROTEIN | FLUORESCENCE | STRUCTURAL BASIS | MULTIDISCIPLINARY SCIENCES | DIFFERENTIAL SCANNING FLUOROMETRY | GENERATION | INFECTION | NEUTRALIZATION | F-GLYCOPROTEIN | Respiratory Syncytial Virus, Human - metabolism | Surface Plasmon Resonance | Microscopy, Electron, Transmission | Respiratory Syncytial Virus Vaccines - immunology | Viral Fusion Proteins - metabolism | Viral Fusion Proteins - genetics | Humans | Antigens - metabolism | Vaccines, Subunit - immunology | Recombinant Proteins - biosynthesis | Viral Fusion Proteins - immunology | Epitopes - immunology | Recombinant Proteins - isolation & purification | Antibodies, Neutralizing - immunology | Recombinant Proteins - immunology | Vaccines, Subunit - metabolism | HEK293 Cells | Respiratory Syncytial Virus Infections - prevention & control | Antibodies, Viral - immunology | Antigens - immunology | Antibodies, Monoclonal - metabolism | Protein Stability | Antigen-Antibody Reactions - immunology | Antibodies, Monoclonal - immunology | Infection | Respiratory tract diseases | Vaccines | Health aspects | Analysis | Antigenic determinants | Elderly people | Antigens | Immunoglobulins | Research & development--R&D | Calcium channels (voltage-gated) | Glycoprotein | Antibodies | Viruses | Infections | Stability analysis | Morbidity | Proteins | Respiratory tract | Infectious diseases | Respiratory syncytial virus | Microscopy | F protein | Adults | Children | Index Medicus | Research & development | R&D
Journal Article
Journal Article
Protein Science, ISSN 0961-8368, 11/2018, Volume 27, Issue 11, pp. 1923 - 1941
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 2011, Volume 6, Issue 3, pp. e17612 - e17612
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 8/2004, Volume 101, Issue 31, pp. 11233 - 11238
Journal Article
Vaccine, ISSN 0264-410X, 05/2018, Volume 36, Issue 20, pp. 2876 - 2885
Journal Article